A Prospective Randomized Open Label Phase III Study of Maintenance Gemcitabine Versus Best Supportive Care Following Platinum-Paclitaxel Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Autor:	Satya Narayan, Harvindra Singh Kumar, Megh Raj Bardia, Saroj Kumari, Surender Beniwal, Akhil Kapoor, P. Kumari, Shankar Lal Jakhar, G. Singh, Mukesh Kumar Singhal
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Hematology medicine.disease Gemcitabine chemistry.chemical_compound Paclitaxel chemistry Internal medicine medicine Non small cell Open label Lung cancer business medicine.drug
Zdroj:	Annals of Oncology. 26:i29
ISSN:	0923-7534
DOI:	10.1093/annonc/mdv050.04
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e8ec7cebaa74ecaeeb4a2884248b2533 https://doi.org/10.1093/annonc/mdv050.04 Zobrazit plný text záznamu